These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 1525850)
1. [Biological effects of anthraquinones. II. Mutagenic, cancerogenic and antineoplastic effects. Effect on the immune system]. Hrones I Cesk Farm; 1992 Jun; 41(3):108-11. PubMed ID: 1525850 [No Abstract] [Full Text] [Related]
2. Design, synthesis and cytotoxic effect of hydroxy- and 3-alkylaminopropoxy-9,10-anthraquinone derivatives. Teng CH; Won SJ; Lin CN Bioorg Med Chem; 2005 May; 13(10):3439-45. PubMed ID: 15848756 [TBL] [Abstract][Full Text] [Related]
3. Peptidyl anthraquinones as potential antineoplastic drugs: synthesis, DNA binding, redox cycling, and biological activity. Gatto B; Zagotto G; Sissi C; Cera C; Uriarte E; Palù G; Capranico G; Palumbo M J Med Chem; 1996 Aug; 39(16):3114-22. PubMed ID: 8759632 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the anti-inflammatory and cytotoxic effects of anthraquinones and anthracenes derivatives in human leucocytes. Chen RF; Shen YC; Huang HS; Liao JF; Ho LK; Chou YC; Wang WY; Chen CF J Pharm Pharmacol; 2004 Jul; 56(7):915-9. PubMed ID: 15233871 [TBL] [Abstract][Full Text] [Related]
5. Selective immunomodulation by the antineoplastic agent mitoxantrone. II. Nonspecific adherent suppressor cells derived from mitoxantrone-treated mice. Fidler JM; DeJoy SQ; Smith FR; Gibbons JJ J Immunol; 1986 Apr; 136(8):2747-54. PubMed ID: 2937837 [TBL] [Abstract][Full Text] [Related]
6. Navelbine and the anthrapyrazoles. Jones AL; Smith IE Hematol Oncol Clin North Am; 1994 Feb; 8(1):141-52. PubMed ID: 8150775 [TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of new anthraquinone derivatives. Ferrazzi E; Palumbo M; Valisena S; Antonello C; Palù G Chemioterapia; 1986 Oct; 5(5):330-6. PubMed ID: 3791481 [TBL] [Abstract][Full Text] [Related]
8. A search for potential antitumor agents: biological effects and DNA binding of a series of anthraquinone derivatives. Palù G; Palumbo M; Antonello C; Meloni GA; Marciani-Magno S Mol Pharmacol; 1986 Feb; 29(2):211-7. PubMed ID: 3951432 [TBL] [Abstract][Full Text] [Related]
9. Immunity during monochemotherapy with mitoxantrone: preliminary results. Cartei G; Contessi E; Comelli M; Turrin D; Toso C; Sibau A; Mian S; Bramezza M J Chemother; 1989 Jul; 1(4 Suppl):1309-10. PubMed ID: 16312879 [No Abstract] [Full Text] [Related]
10. Cytotoxic effect of the association of BCNU with rhein or lonidamine on a human glioma cell line. Floridi A; Gentile PF; Bruno T; Fanciulli M; Paggi MG; Zeuli M; Benassi M Anticancer Res; 1991; 11(2):789-92. PubMed ID: 1648334 [TBL] [Abstract][Full Text] [Related]
11. Cyclopent[a]anthraquinones as DNA intercalating agents with covalent bond formation potential: synthesis and biological activity. Kim JY; Su TL; Chou TC; Koehler B; Scarborough A; Ouerfelli O; Watanabe KA J Med Chem; 1996 Jul; 39(14):2812-8. PubMed ID: 8709111 [TBL] [Abstract][Full Text] [Related]
12. Rhein inhibits the growth and induces the apoptosis of Hep G2 cells. Kuo PL; Hsu YL; Ng LT; Lin CC Planta Med; 2004 Jan; 70(1):12-6. PubMed ID: 14765286 [TBL] [Abstract][Full Text] [Related]
13. [Biological effects of anthraquinones. IV. General toxicity, other effects]. Hrones I Cesk Farm; 1992 Oct; 41(7-8):266-9. PubMed ID: 1490286 [No Abstract] [Full Text] [Related]
14. Effect of lonidamine and rhein on the phosphorylation potential generated by respiring rat liver mitochondria. Miccadei S; Pulselli R; Floridi A Anticancer Res; 1993; 13(5A):1507-10. PubMed ID: 7902063 [TBL] [Abstract][Full Text] [Related]
15. New and cytotoxic anthraquinones from Pleospora sp. IFB-E006, an endophytic fungus in Imperata cylindrical. Ge HM; Song YC; Shan CY; Ye YH; Tan RX Planta Med; 2005 Nov; 71(11):1063-5. PubMed ID: 16320210 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vitro cytotoxic activity of aza- and diazaanthraquinone derivatives. Nebois P; do Nascimento SC; Boitard M; Bartoli MH; Fillion H Pharmazie; 1994 Nov; 49(11):819-21. PubMed ID: 7838868 [TBL] [Abstract][Full Text] [Related]
18. The drug-immune system interaction in cancer therapy. Ghione M Int J Tissue React; 1984; 6(6):513-21. PubMed ID: 6530355 [TBL] [Abstract][Full Text] [Related]
19. On the problems of agents with mutagenic and carcinogenic effects in health care. Cytostatic drugs. Medková J Acta Univ Palacki Olomuc Fac Med; 1990; 126():107-15. PubMed ID: 2151076 [TBL] [Abstract][Full Text] [Related]
20. Effect of Tilorone hydrochloride and congeners on reticuloendothelial system, tumors, and the immune response. Munson AE; Munson JA; Regelson W; Wampler GL Cancer Res; 1972 Jul; 32(7):1397-403. PubMed ID: 5063975 [No Abstract] [Full Text] [Related] [Next] [New Search]